Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | IC50 | = | 1000000 | nM | 9544209 |
NPT116 | Cell Line | HL-60 | Homo sapiens | IC50 | = | 98000 | nM | 16821795 |
NPT783 | Cell Line | MIA PaCa-2 | Homo sapiens | IC50 | = | 15851 | nM | 17944451 |
NPT783 | Cell Line | MIA PaCa-2 | Homo sapiens | IC50 | = | 22101 | nM | 17944451 |
NPT2 | Others | Unspecified | EC50 | = | 200000 | nM | 17726098 | |
NPT530 | Organism | Caenorhabditis elegans | Caenorhabditis elegans | TC50 | = | 2 | nM | 17726098 |
NPT1414 | Organism | Drosophila | Drosophila | TC50 | = | 10 | nM | 17726098 |
NPT530 | Organism | Caenorhabditis elegans | Caenorhabditis elegans | EC50 | = | 700000 | nM | 17726098 |
NPT1414 | Organism | Drosophila | Drosophila | EC50 | = | 1250000 | nM | 17726098 |
NPT2 | Others | Unspecified | Activity | = | 1 | 17726098 | ||
NPT2 | Others | Unspecified | Ki | = | 50000 | nM | 18778048 | |
NPT2 | Others | Unspecified | Activity | = | 0.72 | nmol | 19049348 | |
NPT2 | Others | Unspecified | Potency | = | 10000 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | = | 31622.8 | nM | PubChem BioAssay data set | |
NPT93 | Individual Protein | Survival motor neuron protein | Homo sapiens | Potency | = | 11220.2 | nM | PubChem BioAssay data set |
NPT210 | Individual Protein | Thyroid stimulating hormone receptor | Homo sapiens | Potency | = | 7943.3 | nM | PubChem BioAssay data set |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 22387.2 | nM | PubChem BioAssay data set |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 19952.6 | nM | PubChem BioAssay data set |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 31622.8 | nM | PubChem BioAssay data set |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 25118.9 | nM | PubChem BioAssay data set |
NPT282 | Individual Protein | MAP kinase ERK2 | Homo sapiens | Potency | = | 31622.8 | nM | PubChem BioAssay data set |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 31622.8 | nM | PubChem BioAssay data set |
NPT151 | Individual Protein | 15-hydroxyprostaglandin dehydrogenase [NAD+] | Homo sapiens | Potency | = | 25118.9 | nM | PubChem BioAssay data set |
NPT539 | Individual Protein | Cellular tumor antigen p53 | Homo sapiens | Potency | = | 19952.6 | nM | PubChem BioAssay data set |
NPT2911 | Organism | Pseudomonas putida | Pseudomonas putida | Activity | = | 90 | % | 19822705 |
NPT532 | Individual Protein | Lysine-specific demethylase 4A | Homo sapiens | Potency | 89125.1 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 23109.3 | nM | PubChem BioAssay data set | ||
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 23109.3 | nM | PubChem BioAssay data set | |
NPT443 | Individual Protein | Histone acetyltransferase GCN5 | Homo sapiens | Potency | 11220.2 | nM | PubChem BioAssay data set | |
NPT108 | Individual Protein | Estrogen receptor alpha | Homo sapiens | Potency | 28183.8 | nM | PubChem BioAssay data set | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 39810.7 | nM | PubChem BioAssay data set | |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Potency | 5.6 | nM | PubChem BioAssay data set | |
NPT586 | Organism | Giardia | Giardia | Potency | 2305.3 | nM | PubChem BioAssay data set | |
NPT249 | Individual Protein | Glucocorticoid receptor | Homo sapiens | Potency | 5011.9 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 66824.2 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 10000 | nM | PubChem BioAssay data set | ||
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 281.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 37578 | nM | PubChem BioAssay data set | ||
NPT158 | Individual Protein | Nuclear receptor subfamily 1 group I member 2 | Rattus norvegicus | Potency | 50118.7 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 21131.7 | nM | PubChem BioAssay data set | ||
NPT103 | Individual Protein | Nuclear receptor ROR-gamma | Homo sapiens | Potency | 6682.4 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 29092.9 | nM | PubChem BioAssay data set | ||
NPT160 | Individual Protein | TAR DNA-binding protein 43 | Homo sapiens | Potency | 15848.9 | nM | PubChem BioAssay data set | |
NPT839 | Cell Line | L6 | Rattus norvegicus | Activity | = | 0.42 | umol/ml | 23750537 |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 75.05 | % | 23571415 |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 78.36 | % | 23571415 |
NPT2 | Others | Unspecified | Inhibition | = | 77 | % | 24147937 | |
NPT2 | Others | Unspecified | IC50 | = | 20000 | nM | 24147937 | |
NPT175 | Organism | Enterococcus faecalis | Enterococcus faecalis | MIC | > | 50 | ug/ml | 24360560 |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | > | 50 | ug/ml | 24360560 |
NPT878 | Organism | Streptococcus mutans | Streptococcus mutans | MIC | > | 50 | ug/ml | 24360560 |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 25 | ug/ml | 24360560 |
NPT2 | Others | Unspecified | MIC | > | 50 | ug/ml | 24360560 | |
NPT2900 | Organism | Bifidobacterium longum | Bifidobacterium longum | MIC | = | 25 | ug/ml | 24360560 |
NPT3572 | Organism | Bacteroides thetaiotaomicron | Bacteroides thetaiotaomicron | MIC | = | 25 | ug/ml | 24360560 |
NPT2 | Others | Unspecified | MIC | = | 12.5 | ug/ml | 24360560 | |
NPT2 | Others | Unspecified | MIC | = | 50 | ug/ml | 24360560 | |
NPT2 | Others | Unspecified | Potency | 17228.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 38727.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 38895.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 34813.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 17448.3 | nM | PubChem BioAssay data set | ||
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 15484.5 | nM | PubChem BioAssay data set | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 4382.8 | nM | PubChem BioAssay data set | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 61130.6 | nM | PubChem BioAssay data set | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 68868.7 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 30637.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 61379.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1100.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 43453.2 | nM | PubChem BioAssay data set | ||
NPT535 | Individual Protein | Parathyroid hormone receptor | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 48966.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 31027.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 43641.2 | nM | PubChem BioAssay data set | ||
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 15355.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 688.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 6164.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 61130.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 544.8 | nM | PubChem BioAssay data set | ||
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 48755.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 54704.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 9811.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 68589.6 | nM | PubChem BioAssay data set | ||
NPT106 | Individual Protein | Peroxisome proliferator-activated receptor delta | Homo sapiens | Potency | 9811.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 68868.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 30762.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 34376.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 24435.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 54941 | nM | PubChem BioAssay data set | ||
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 5517.6 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 27306 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 6946.3 | nM | PubChem BioAssay data set | ||
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 17373.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 55176.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 19952.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 17373.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 27417.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 61908.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 3481.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 21872.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 10962.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 6886.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 3857.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 54482.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 491.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 10915 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 10870.7 | nM | PubChem BioAssay data set | ||
NPT1627 | Individual Protein | G-protein coupled receptor 35 | Homo sapiens | EC50 | = | 272000 | nM | 10.1039/C2MD20210G |
NPT1627 | Individual Protein | G-protein coupled receptor 35 | Homo sapiens | EC50 | = | 31100 | nM | 10.1039/C2MD20210G |
NPT2 | Others | Unspecified | Potency | 77272 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 12299.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 19577.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 35481.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 27535.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 17299 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 19409.8 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC321869 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.8919 | High Similarity | NPC44836 |
0.8205 | Intermediate Similarity | NPC329358 |
0.807 | Intermediate Similarity | NPC311660 |
0.7895 | Intermediate Similarity | NPC70201 |
0.7851 | Intermediate Similarity | NPC322735 |
0.7815 | Intermediate Similarity | NPC255721 |
0.7787 | Intermediate Similarity | NPC329190 |
0.7647 | Intermediate Similarity | NPC76327 |
0.725 | Intermediate Similarity | NPC256838 |
0.7174 | Intermediate Similarity | NPC317872 |
0.704 | Intermediate Similarity | NPC9336 |
0.7031 | Intermediate Similarity | NPC222982 |
0.6875 | Remote Similarity | NPC264782 |
0.6846 | Remote Similarity | NPC40209 |
0.6761 | Remote Similarity | NPC122542 |
0.6714 | Remote Similarity | NPC313466 |
0.6621 | Remote Similarity | NPC47986 |
0.662 | Remote Similarity | NPC91615 |
0.6575 | Remote Similarity | NPC314113 |
0.6449 | Remote Similarity | NPC315632 |
0.6395 | Remote Similarity | NPC314252 |
0.6284 | Remote Similarity | NPC181526 |
0.6284 | Remote Similarity | NPC204156 |
0.626 | Remote Similarity | NPC226914 |
0.6241 | Remote Similarity | NPC314278 |
0.6216 | Remote Similarity | NPC469828 |
0.619 | Remote Similarity | NPC159589 |
0.6181 | Remote Similarity | NPC473987 |
0.6164 | Remote Similarity | NPC297584 |
0.6159 | Remote Similarity | NPC168750 |
0.6149 | Remote Similarity | NPC43218 |
0.6149 | Remote Similarity | NPC316574 |
0.6126 | Remote Similarity | NPC100980 |
0.6118 | Remote Similarity | NPC260601 |
0.6104 | Remote Similarity | NPC315829 |
0.6098 | Remote Similarity | NPC476483 |
0.6093 | Remote Similarity | NPC470090 |
0.609 | Remote Similarity | NPC280382 |
0.6084 | Remote Similarity | NPC95898 |
0.6063 | Remote Similarity | NPC29601 |
0.6053 | Remote Similarity | NPC65517 |
0.604 | Remote Similarity | NPC159722 |
0.604 | Remote Similarity | NPC166667 |
0.6039 | Remote Similarity | NPC473769 |
0.6031 | Remote Similarity | NPC37584 |
0.6013 | Remote Similarity | NPC323798 |
0.6 | Remote Similarity | NPC70549 |
0.5987 | Remote Similarity | NPC476462 |
0.5986 | Remote Similarity | NPC208022 |
0.594 | Remote Similarity | NPC172046 |
0.5933 | Remote Similarity | NPC126637 |
0.5926 | Remote Similarity | NPC306366 |
0.5924 | Remote Similarity | NPC241392 |
0.5897 | Remote Similarity | NPC204932 |
0.5872 | Remote Similarity | NPC471785 |
0.5847 | Remote Similarity | NPC270094 |
0.5843 | Remote Similarity | NPC44161 |
0.5839 | Remote Similarity | NPC112766 |
0.5833 | Remote Similarity | NPC146370 |
0.5806 | Remote Similarity | NPC470394 |
0.5806 | Remote Similarity | NPC470404 |
0.5806 | Remote Similarity | NPC470403 |
0.5804 | Remote Similarity | NPC215445 |
0.5763 | Remote Similarity | NPC4154 |
0.5736 | Remote Similarity | NPC125732 |
0.5732 | Remote Similarity | NPC231862 |
0.5732 | Remote Similarity | NPC470395 |
0.5725 | Remote Similarity | NPC178902 |
0.5723 | Remote Similarity | NPC204179 |
0.5707 | Remote Similarity | NPC111492 |
0.5697 | Remote Similarity | NPC57105 |
0.5697 | Remote Similarity | NPC79911 |
0.5696 | Remote Similarity | NPC220523 |
0.5692 | Remote Similarity | NPC155847 |
0.5692 | Remote Similarity | NPC289381 |
0.5686 | Remote Similarity | NPC476475 |
0.5683 | Remote Similarity | NPC317254 |
0.568 | Remote Similarity | NPC151764 |
0.5677 | Remote Similarity | NPC301702 |
0.5674 | Remote Similarity | NPC229353 |
0.5673 | Remote Similarity | NPC290069 |
0.5669 | Remote Similarity | NPC473874 |
0.5667 | Remote Similarity | NPC15839 |
0.566 | Remote Similarity | NPC257142 |
0.5658 | Remote Similarity | NPC475707 |
0.5647 | Remote Similarity | NPC225381 |
0.5644 | Remote Similarity | NPC477889 |
0.5643 | Remote Similarity | NPC147957 |
0.5641 | Remote Similarity | NPC322285 |
0.564 | Remote Similarity | NPC220560 |
0.5636 | Remote Similarity | NPC120798 |
0.563 | Remote Similarity | NPC307456 |
0.5617 | Remote Similarity | NPC36168 |
0.5612 | Remote Similarity | NPC118202 |
0.5606 | Remote Similarity | NPC68055 |
0.5606 | Remote Similarity | NPC178681 |
0.5603 | Remote Similarity | NPC311737 |
0.5603 | Remote Similarity | NPC38458 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC321869 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.7787 | Intermediate Similarity | NPD286 | Approved |
0.7647 | Intermediate Similarity | NPD9507 | Approved |
0.7581 | Intermediate Similarity | NPD9342 | Approved |
0.7317 | Intermediate Similarity | NPD9376 | Approved |
0.7021 | Intermediate Similarity | NPD204 | Clinical (unspecified phase) |
0.6992 | Remote Similarity | NPD522 | Approved |
0.6846 | Remote Similarity | NPD711 | Discontinued |
0.6806 | Remote Similarity | NPD521 | Clinical (unspecified phase) |
0.6794 | Remote Similarity | NPD9247 | Phase 3 |
0.6688 | Remote Similarity | NPD935 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD254 | Approved |
0.662 | Remote Similarity | NPD756 | Suspended |
0.6599 | Remote Similarity | NPD965 | Approved |
0.6547 | Remote Similarity | NPD9723 | Approved |
0.6541 | Remote Similarity | NPD313 | Approved |
0.6538 | Remote Similarity | NPD3241 | Phase 2 |
0.6467 | Remote Similarity | NPD1084 | Clinical (unspecified phase) |
0.6398 | Remote Similarity | NPD1293 | Approved |
0.6323 | Remote Similarity | NPD1162 | Approved |
0.6319 | Remote Similarity | NPD1220 | Phase 1 |
0.6301 | Remote Similarity | NPD9695 | Approved |
0.6294 | Remote Similarity | NPD1314 | Clinical (unspecified phase) |
0.6284 | Remote Similarity | NPD3391 | Approved |
0.6212 | Remote Similarity | NPD308 | Approved |
0.621 | Remote Similarity | NPD9070 | Clinical (unspecified phase) |
0.6205 | Remote Similarity | NPD1221 | Approved |
0.619 | Remote Similarity | NPD471 | Approved |
0.6164 | Remote Similarity | NPD1393 | Approved |
0.6149 | Remote Similarity | NPD9279 | Approved |
0.6149 | Remote Similarity | NPD6636 | Phase 3 |
0.6138 | Remote Similarity | NPD9471 | Clinical (unspecified phase) |
0.6126 | Remote Similarity | NPD9087 | Approved |
0.6118 | Remote Similarity | NPD5819 | Phase 2 |
0.6118 | Remote Similarity | NPD1196 | Approved |
0.6107 | Remote Similarity | NPD5788 | Clinical (unspecified phase) |
0.6099 | Remote Similarity | NPD1158 | Phase 2 |
0.6098 | Remote Similarity | NPD1394 | Approved |
0.6087 | Remote Similarity | NPD1191 | Discontinued |
0.6069 | Remote Similarity | NPD3398 | Discontinued |
0.6053 | Remote Similarity | NPD1195 | Approved |
0.6053 | Remote Similarity | NPD9088 | Approved |
0.6026 | Remote Similarity | NPD9509 | Clinical (unspecified phase) |
0.6 | Remote Similarity | NPD1543 | Discontinued |
0.5975 | Remote Similarity | NPD1557 | Discontinued |
0.5972 | Remote Similarity | NPD1160 | Phase 2 |
0.5963 | Remote Similarity | NPD6283 | Phase 2 |
0.596 | Remote Similarity | NPD1422 | Approved |
0.593 | Remote Similarity | NPD9468 | Clinical (unspecified phase) |
0.5926 | Remote Similarity | NPD3558 | Approved |
0.5926 | Remote Similarity | NPD3560 | Approved |
0.5926 | Remote Similarity | NPD3559 | Clinical (unspecified phase) |
0.5926 | Remote Similarity | NPD3557 | Approved |
0.5926 | Remote Similarity | NPD3556 | Approved |
0.5897 | Remote Similarity | NPD2114 | Discontinued |
0.5894 | Remote Similarity | NPD822 | Approved |
0.5847 | Remote Similarity | NPD9089 | Approved |
0.5843 | Remote Similarity | NPD6379 | Discontinued |
0.5839 | Remote Similarity | NPD1187 | Discontinued |
0.5805 | Remote Similarity | NPD6045 | Phase 3 |
0.5783 | Remote Similarity | NPD3251 | Approved |
0.5776 | Remote Similarity | NPD3684 | Discontinued |
0.5776 | Remote Similarity | NPD948 | Phase 3 |
0.5763 | Remote Similarity | NPD9093 | Approved |
0.5753 | Remote Similarity | NPD848 | Approved |
0.5753 | Remote Similarity | NPD849 | Approved |
0.5753 | Remote Similarity | NPD850 | Approved |
0.575 | Remote Similarity | NPD9715 | Phase 2 |
0.5749 | Remote Similarity | NPD3511 | Discontinued |
0.5741 | Remote Similarity | NPD3778 | Approved |
0.5724 | Remote Similarity | NPD9587 | Clinical (unspecified phase) |
0.5723 | Remote Similarity | NPD1405 | Approved |
0.5714 | Remote Similarity | NPD457 | Approved |
0.5714 | Remote Similarity | NPD7083 | Clinical (unspecified phase) |
0.5714 | Remote Similarity | NPD5639 | Clinical (unspecified phase) |
0.5705 | Remote Similarity | NPD2241 | Approved |
0.5689 | Remote Similarity | NPD2341 | Discontinued |
0.5687 | Remote Similarity | NPD8330 | Clinical (unspecified phase) |
0.5686 | Remote Similarity | NPD1169 | Approved |
0.5682 | Remote Similarity | NPD9608 | Approved |
0.5682 | Remote Similarity | NPD9610 | Approved |
0.5677 | Remote Similarity | NPD75 | Approved |
0.5677 | Remote Similarity | NPD9277 | Approved |
0.5673 | Remote Similarity | NPD6645 | Clinical (unspecified phase) |
0.5662 | Remote Similarity | NPD909 | Clinical (unspecified phase) |
0.5652 | Remote Similarity | NPD1633 | Approved |
0.5652 | Remote Similarity | NPD1678 | Clinical (unspecified phase) |
0.5652 | Remote Similarity | NPD950 | Clinical (unspecified phase) |
0.5652 | Remote Similarity | NPD456 | Approved |
0.5633 | Remote Similarity | NPD3141 | Discontinued |
0.5632 | Remote Similarity | NPD5637 | Discontinued |
0.5629 | Remote Similarity | NPD3252 | Approved |
0.5622 | Remote Similarity | NPD1621 | Discontinued |
0.5617 | Remote Similarity | NPD3229 | Phase 2 |
0.5617 | Remote Similarity | NPD1634 | Approved |
0.5613 | Remote Similarity | NPD9278 | Suspended |
0.5613 | Remote Similarity | NPD9245 | Clinical (unspecified phase) |
0.5613 | Remote Similarity | NPD9275 | Approved |
0.5613 | Remote Similarity | NPD9274 | Approved |
0.5613 | Remote Similarity | NPD9276 | Approved |
0.5611 | Remote Similarity | NPD4740 | Approved |
PubChem CID   | 1493 |
ChEMBL   | CHEMBL273386 |
ZINC   |
Molecular Weight:   | 184.01 |
ALogP:   | 0.8599 |
MLogP:   | 1.35 |
XLogP:   | 2.465 |
# Rotatable Bonds:   | 5 |
Polar Surface Area:   | 106.51 |
# H-Bond Aceptor:   | 0 |
# H-Bond Donor:   | 1 |
# Rings:   | 1 |
# Heavy Atoms:   | 13 |